StreetInsider.com News Articles

Form 10-Q Cell Source, Inc. For: Mar 31

Thu, 14 May 2026 12:33:00 -0400

si-local-file:///var/storage/secattach/20260514/26492757.html

Form 10-Q Cell Source, Inc. For: Mar 31

Thu, 14 May 2026 12:33:00 -0400

si-local-file:///var/storage/secattach/20260514/26492757.html

Form 10-K Cell Source, Inc. For: Dec 31

Tue, 07 Apr 2026 06:01:00 -0400

si-local-file:///var/storage/secattach/20260407/26280168.html

Form 10-K Cell Source, Inc. For: Dec 31

Tue, 07 Apr 2026 06:01:00 -0400

si-local-file:///var/storage/secattach/20260407/26280168.html

Form 15-12G Cell Source, Inc.

Wed, 16 Jul 2025 16:25:00 -0400

si-local-file:///var/storage/secattach/20250716/25060368.html

Form 15-12G Cell Source, Inc.

Wed, 16 Jul 2025 16:25:00 -0400

si-local-file:///var/storage/secattach/20250716/25060368.html

Form 8-K Cell Source, Inc. For: Jun 26

Fri, 27 Jun 2025 11:51:00 -0400

si-local-file:///var/storage/secattach/20250627/24988571.html

Form 8-K Cell Source, Inc. For: Jun 26

Fri, 27 Jun 2025 11:51:00 -0400

si-local-file:///var/storage/secattach/20250627/24988571.html

Form NT 10-K Cell Source, Inc. For: Dec 31

Fri, 28 Mar 2025 11:12:00 -0400

si-local-file:///var/storage/secattach/20250328/24563727.html

Form NT 10-K Cell Source, Inc. For: Dec 31

Fri, 28 Mar 2025 11:12:00 -0400

si-local-file:///var/storage/secattach/20250328/24563727.html

Cell Source Presents Potential Breakthrough in the Development of Off-the-Shelf CAR-T Cell Therapy at American Society of Hematology Annual Meeting

Thu, 19 Dec 2024 16:00:00 -0400

Research Presented at the American Society of Hematology Annual Meeting Highlights New Mechanisms to Overcome Immune Rejection

NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Cell Source, Inc. (OTCQB:CLCS) ("Cell Source" or the "Company"), a leading innovator in immune tolerance management, recently presented promising preclinical findings at the 2024 American Society of Hematology (ASH) Annual Meeting. The research showcased how the company's proprietary Veto Cell technology can overcome one of the most critical barriers in allogeneic cell therapy - natural killer (NK) cell-mediated rejection. This innovation brings the field closer to realizing

Cell Source Presents Potential Breakthrough in the Development of Off-the-Shelf CAR-T Cell Therapy at American Society of Hematology Annual Meeting

Thu, 19 Dec 2024 16:00:00 -0400

Research Presented at the American Society of Hematology Annual Meeting Highlights New Mechanisms to Overcome Immune Rejection

Cell Source Shares Promising Interim Results From Groundbreaking Veto Cell Clinical Trial

Thu, 21 Nov 2024 08:00:00 -0400

First-of-Its-Kind Success in Mismatched Donor Stem Cell Transplantation: Engraftment Under Mild Immune Suppression with Minimal Graft-versus-Host Disease

NEW YORK, NY / ACCESSWIRE / November 21, 2024 / Cell Source, Inc. (OTCQB:CLCS) ("Cell Source", or the "Company"), a pioneer in Veto Cell-based immunotherapy, today shared positive interim results from its Phase 1/2 First-in-Human clinical trial conducted at The University of Texas MD Anderson Cancer Center. The trial has treated 15 patients using Cell Source's proprietary Veto Cell technology in stem cell transplants for malignant and non-malignant hematologic diseases. These early results indicate both safety and efficacy,

Cell Source Shares Promising Interim Results From Groundbreaking Veto Cell Clinical Trial

Thu, 21 Nov 2024 08:00:00 -0400

First-of-Its-Kind Success in Mismatched Donor Stem Cell Transplantation: Engraftment Under Mild Immune Suppression with Minimal Graft-versus-Host Disease

Form 10-Q Cell Source, Inc. For: Sep 30

Thu, 14 Nov 2024 16:38:00 -0400

si-local-file:///var/storage/secattach/20241114/23987376.html

Form 10-Q Cell Source, Inc. For: Sep 30

Thu, 14 Nov 2024 16:38:00 -0400

si-local-file:///var/storage/secattach/20241114/23987376.html

Form 10-Q Cell Source, Inc. For: Jun 30

Mon, 19 Aug 2024 15:13:00 -0400

si-local-file:///var/storage/secattach/20240819/23617798.html

Form 10-Q Cell Source, Inc. For: Jun 30

Mon, 19 Aug 2024 15:13:00 -0400

si-local-file:///var/storage/secattach/20240819/23617798.html

Form NT 10-Q Cell Source, Inc. For: Jun 30

Wed, 14 Aug 2024 14:01:00 -0400

si-local-file:///var/storage/secattach/20240814/23600543.html

Form NT 10-Q Cell Source, Inc. For: Jun 30

Wed, 14 Aug 2024 14:01:00 -0400

si-local-file:///var/storage/secattach/20240814/23600543.html

Form 10-Q Cell Source, Inc. For: Mar 31

Mon, 29 Jul 2024 17:08:00 -0400

si-local-file:///var/storage/secattach/20240729/23519093.html

Form 10-Q Cell Source, Inc. For: Mar 31

Mon, 29 Jul 2024 17:08:00 -0400

si-local-file:///var/storage/secattach/20240729/23519093.html

Form 10-K Cell Source, Inc. For: Dec 31

Mon, 24 Jun 2024 11:51:00 -0400

si-local-file:///var/storage/secattach/20240624/23388769.html

Form 10-K Cell Source, Inc. For: Dec 31

Mon, 24 Jun 2024 11:51:00 -0400

si-local-file:///var/storage/secattach/20240624/23388769.html

Form 8-K Cell Source, Inc. For: Mar 22

Tue, 09 Apr 2024 12:06:00 -0400

si-local-file:///var/storage/secattach/20240409/23045457.html